PerkinElmer, Inc. (United States)
(NYSE : PKI)

( )
PKI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.03%540.111.0%$849.06m
DHRDanaher Corp. 0.00%251.710.7%$688.29m
ABTAbbott Laboratories 0.02%114.890.8%$659.02m
ISRGIntuitive Surgical, Inc. 0.15%223.630.8%$512.78m
MDTMedtronic Plc -0.60%98.980.6%$493.78m
BSXBoston Scientific Corp. 1.79%40.881.0%$384.33m
ALGNAlign Technology, Inc. 0.00%274.836.4%$375.45m
IDXXIDEXX Laboratories, Inc. 0.00%384.923.8%$360.98m
SYKStryker Corp. 0.00%234.951.3%$344.49m
EWEdwards Lifesciences Corp. -0.01%98.560.4%$316.81m
BDXBecton, Dickinson & Co. -0.23%251.911.0%$311.50m
DXCMDexCom, Inc. -2.62%273.277.7%$303.30m
AAgilent Technologies, Inc. -0.07%123.761.6%$263.00m
BAXBaxter International, Inc. -0.05%75.711.8%$248.58m
MTDMettler-Toledo International, Inc. 0.03%1258.895.8%$196.60m

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.